aveni is the leading developer and supplier of Electrografting™ chemistries and processes for the semiconductor and electronics industry. Headquartered in Massy, France, the company has a worldwide reputation for providing transformative chemistries and processes, coupled with the technology transfer capability to enable smooth transition of its solutions into production. For more information, visit aveni.com


Team Members
more about
Roel Bulthuis
more about
Christian Patze
Latest News Entry
aveni® S.A. Raises €8.9M ($10.5M) in Series B Financing from Merck Ventures and Existing Investors to Commercialize its Innovative Metallization Technologies

PARIS, France – October 24, 2017 aveni S.A., developer and manufacturer of market disrupting wet deposition technologies and chemistries for 2D interconnects and 3D TSV packaging, today announced it has completed a €8.9M ($10.5M) capital raise from Merck Ventures, the corporate venture arm of Merck, along with existing investors.

all portfolio news